Premium
RELAPSED AND REFRACTORY NODULAR LYMPHOCYTE‐PREDOMINANT HODGKIN LYMPHOMA (NLPHL): A US ANALYSIS FROM MD ANDERSON CANCER CENTER
Author(s) -
Strati P.,
Alcedo Andreade P.,
Sano D.,
Rao V.,
Singh P.,
Miranda R.,
Gunther J.,
Pinnix C.,
Dabaja B.,
Lee H.J.,
Steiner R.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.182_2631
Subject(s) - medicine , rituximab , abvd , chemotherapy , chemotherapy regimen , refractory (planetary science) , brentuximab vedotin , autologous stem cell transplantation , progression free survival , oncology , vincristine , surgery , lymphoma , gastroenterology , cyclophosphamide , hodgkin lymphoma , astrobiology , physics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom